Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: Preliminary results

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 2, 2011, Pages 56-59

  Fabiano, Adele ^a   Gazzolo, Diego ^b   Zimmermann, Luc J I ^c   Gavilanes, Antonio W D ^c   Paolillo, Piermichele ^a   Fanos, Vassilios ^d   Caboni, Pierluigi ^d   Barberini, Luigi ^d   Noto, Antonio ^d   Atzori, Luigi ^d  

^a Casilino General Hospital   (Italy)

^b C Arrigo Children's Hospital   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

BALF; BPD; Metabolomics; Newborn; Prematurity; RDS

Indexed keywords

DECANOIC ACID; LAURIC ACID; LIGNOCERIC ACID; LUNG SURFACTANT; MYRISTIC ACID; PALMITIC ACID; PALMITIC ACID METHYL ESTER; PHOSPHATE; PORACTANT; STEARIC ACID; STEARIC ACID DERIVATIVE;

ARTICLE; ARTIFICIAL VENTILATION; BREATHING RATE; CHEMICAL STRUCTURE; CLINICAL ARTICLE; EXTUBATION; GESTATIONAL AGE; HUMAN; INSPIRATORY CAPACITY; LUNG LAVAGE; MASS FRAGMENTOGRAPHY; METABOLOMICS; NEONATAL RESPIRATORY DISTRESS SYNDROME; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; VERY LOW BIRTH WEIGHT; CHEMISTRY; EVALUATION; FEMALE; MALE; METABOLISM; METHODOLOGY; NEWBORN; NUCLEAR MAGNETIC RESONANCE; PATHOLOGY; PILOT STUDY; VALIDATION STUDY;

BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PILOT PROJECTS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 80053270400     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.606977     Document Type: Article

References (26)

1. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011;23:305-313.
2. Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 2006;30:164-170. (Pubitemid 44062673)
3. Fanaroff AA, Hack M, Walsh MC. The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 2003;27:281-287. (Pubitemid 37099808)
4. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
5. Ambalavanan N, Carlo WA. Bronchopulmonary dysplasia: new insights. Clin Perinatol 2004;31:613-628. (Pubitemid 39119488)
6. Been JV, Debeer A, van Iwaarden JF, Kloosterboer N, Passos VL, Naulaers G, Zimmermann LJ. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Res 2010;67:83-89.
7. Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Pediatrics 2009;123:1541-1547.
8. Been JV, Zimmermann LJ, Debeer A, Kloosterboer N, van Iwaarden JF. Bronchoalveolar lavage fluid from preterm infants with chorioamnionitis inhibits alveolar epithelial repair. Respir Res 2009;10:116.
9. Ellis DI, Dunn WB, Griffin JL, Allwood JW, Goodacre R. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 2007;8:1243-1266. (Pubitemid 47578232)
10. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011;40:387-426.
11. Holmes E, Tsang TM, Tabrizi SJ. The application of NMR-based metabonomics in neurological disorders. NeuroRx 2006;3:358-372. (Pubitemid 43964900)
12. Yang Y, Li C, Nie X, Feng X, Chen W, Yue Y, Tang H, Deng F. Metabonomic studies of human hepatocellular carcinoma using highresolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. J Proteome Res 2007;6:2605-2614. (Pubitemid 47122355)
13. Wolak JE, Esther CR Jr, OConnell TM. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers 2009;14:55-60.
14. Atzori L, Antonucci R, Barberini L, Locci E, Cesare Marincola F, Scano P, Cortesi P, et al. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed) 2010;2:725-732.
15. Carraro S, Rezzi S, Reniero F, Héberger K, Giordano G, Zanconato S, Guillou C, Baraldi E. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007;175:986-990. (Pubitemid 46741749)
16. Atzori L, Antonucci R, Barberini L, Locci E, Marincola FC, Scano P, Cortesi P, et al. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011;3: 1005-1012.
17. Campbell S, Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynaecol 1977;84:165-174. (Pubitemid 8114019)
18. Biban P, Filipovic-Grcic B, Biarent D, Manzoni P. International Liaison Committee on Resuscitation (ILCOR); European Resuscitation Council (ERC); American Heart Association (AHA); American Academy of Pediatrics (AAP). New cardiopulmonary resuscitation guidelines 2010: managing the newly born in delivery room. Early Hum Dev 2011;87:S9-11.
19. Zecca E, De Luca D, Baroni S, Vento G, Tiberi E, Romagnoli C. Bile acid-induced lung injury in newborn infants: a bronchoalveolar lavage fluid study. Pediatrics 2008;121:e146-e149.
20. Lundberg, Vogel, Malusek, Lundquist, Cohen, Dahlqvist (nomi). The Magnetic Resonance Metabolomic Database (mdl.imv.liu.se), ESMRMB, Basel, Switzerland. 2005
21. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007;35:D521-D526. (Pubitemid 46056263)
22. NMR and LC/GC/MS processing, analysis, managing and reporting. Available from http://www.mestrelab.com
23. Auffray C, Adcock IM, Chung KF, Djukanovic R, Pison C, Sterk PJ. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010;137:1410-1416.
24. Perpiñá Tordera M. Complexity in asthma: inflammation and scalefree networks. Arch Bronconeumol 2009;45:459-465.
25. Louhelainen N, Myllärniemi M, Rahman I, Kinnula VL. Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives. Int J Chron Obstruct Pulmon Dis 2008;3:585-603.
26. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L152-L161.